npj Genomic MedicineGenetic & Genomic MedicinePeer-reviewed journal article
metPropagate: network-guided propagation of metabolomic information for prioritization of neurometabolic disease genes
Emma J. Graham Linck, Phillip A. RichmondiD, Maja Tarailo‐GraovaciD, Udo F. H. EngelkeiD, Leo A. J. KluijtmansiD, Karlien L. M. CoeneiD, Ron A. WeversiD, Wyeth W. WassermaniD, Clara van KarnebeekiD, Sara MostafaviiD
Abstract
Many inborn errors of metabolism (IEMs) are amenable to treatment, therefore early diagnosis before irreversible damage occurs is imperative. Despite recent advances, the genetic basis of many metabolic phenotypes remains unknown. For discovery purposes, Whole Exome Sequencing (WES) variant prioritization coupled with phenotype-guided clinical and bioinformatics expertise is currently the primary method used to identify novel disease-causing variants; however, it can be challenging to identify the causal candidate gene given the large number of plausible variants. Using untargeted metabolomics (UM) to prioritize metabolically relevant candidate genes is a promising approach to diagnosing known or novel IEMs in a single patient. Here, we present a network-based bioinformatics approach, metPropagate, that uses UM data from a single patient and a group of controls to prioritize candidate genes. We validate metProp on 107 patients with diagnosed IEMs and 11 patients with novel IEMs diagnosed through the TIDE gene discovery project at BC Childrens Hospital. The metPropagate method ranks candidate genes by considering the network of interactions between them. This is done by using a graph smoothing algorithm called label propagation to quantify the metabolic disruption in genes local neighbourhood. metPropagate was able to prioritize the causative gene in the top 20th percentile of candidate genes for 91% of patients with known IEM disorders. For novel IEMs, metPropagate placed the causative gene in the top 20th percentile in 9/11 patients. Using metPropagate, the causative gene was ranked higher than Exomisers phenotype-based ranking in 6/11 patients. The results of this study indicate that for diagnostic and gene discovery purposes, network-based analysis of metabolomics data can lend support to WES gene-discovery methods by providing an additional mode of evidence to help identify causal genes.
- organism: human
- assay: metabolomics
- assay: whole-exome sequencing
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: variant effect prediction
- approach: statistical model
- approach: graph neural network
- Citations
- 22
- FWCI
- 2.05
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prioritizing disease-causing metabolic genes by integrating metabolomics with whole exome sequencing data
Michiel Bongaerts, Ramon Bonte, … George J. G. Ruijter·Molecular Genetics and MetabolismPeer-reviewed·May 25, 2022
- Metabolic landscape of inborn errors of metabolism
Min Ni, Ling Cai, … Ralph J. DeBerardinis·medRxiv·Oct 29, 2026
- Integrating untargeted metabolomics, genetically informed causal inference, and pathway enrichment to define the obesity metabolome
Yu-Han H. Hsu, Christina M. Astley, … Joel N. Hirschhorn·International Journal of ObesityPeer-reviewed·May 28, 2020
- metGWAS 1.0: An R workflow for network-driven over-representation analysis between independent metabolomic and meta-genome wide association studies
Saifur Rahman Khan, Andreea Obersterescu, … Brian Cox·BioinformaticsPeer-reviewed·Aug 23, 2023
- A multiomic network approach uncovers disease modifying mechanisms of inborn errors of metabolism
Aaron S. Bender, Pablo Ranea‐Robles, … Carmen Argmann·Journal of Inherited Metabolic DiseasePeer-reviewed·May 30, 2025
- Extending Inherited Metabolic Disorder diagnostics with Biomarker Interaction Visualizations
Denise Slenter, Irene M. G. M. Hemel, … Laura K.M. Steinbusch·Orphanet Journal of Rare DiseasesPeer-reviewed·Apr 26, 2023